Literature DB >> 25675114

Estrogen and Estrogen Receptor-α-Mediated Transrepression of Bile Salt Export Pump.

Yuan Chen1, Alex Vasilenko, Xiulong Song, Leila Valanejad, Ruchi Verma, Sangmin You, Bingfang Yan, Stephanie Shiffka, Leeza Hargreaves, Christina Nadolny, Ruitang Deng.   

Abstract

Among diseases unique to pregnancy, intrahepatic cholestasis of pregnancy is the most prevalent disorder with elevated serum bile acid levels. We have previously shown that estrogen 17β-estradiol (E2) transrepresses bile salt export pump (BSEP) through an interaction between estrogen receptor (ER)-α and farnesoid X receptor (FXR) and transrepression of BSEP by E2/ERα is an etiological contributing factor to intrahepatic cholestasis of pregnancy. Currently the mechanistic insights into such transrepression are not fully understood. In this study, the dynamics of coregulator recruitment to BSEP promoter after FXR activation and E2 treatment were established with quantitative chromatin immunoprecipitation assays. Coactivator peroxisome proliferator-activated receptor-γ coactivator-1 was predominantly recruited to the BSEP promoter upon FXR activation, and its recruitment was decreased by E2 treatment. Meanwhile, recruitment of nuclear receptor corepressor was markedly increased upon E2 treatment. Functional evaluation of ERα and ERβ chimeras revealed that domains AC of ERα are the determinants for ERα-specific transrepression on BSEP. Further studies with various truncated ERα proteins identified the domains in ERα responsible for ligand-dependent and ligand-independent transrepression. Truncated ERα-AD exhibited potent ligand-independent transrepressive activity, whereas ERα-CF was fully capable of transrepressing BSEP ligand dependently in vitro in Huh 7 cells and in vivo in mice. Both ERα-AD and ERα-CF proteins were associated with FXR in the coimmunoprecipitation assays. In conclusion, E2 repressed BSEP expression through diminishing peroxisome proliferator-activated receptor-γ coactivator-1 recruitment with a concurrent increase in nuclear receptor corepressor recruitment to the BSEP promoter. Domains AD and CF in ERα mediated ligand-independent and ligand-dependent transrepression on BSEP, respectively, through interacting with FXR.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25675114      PMCID: PMC4399276          DOI: 10.1210/me.2015-1014

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  54 in total

1.  Variant estrogen receptors and their role in liver disease.

Authors:  Erica Villa; Alessandra Colantoni; Antonella Grottola; Ilva Ferretti; Paola Buttafoco; Helga Bertani; Nicola De Maria; Federico Manenti
Journal:  Mol Cell Endocrinol       Date:  2002-07-31       Impact factor: 4.102

2.  Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.

Authors:  P L Jansen; S S Strautnieks; E Jacquemin; M Hadchouel; E M Sokal; G J Hooiveld; J H Koning; A De Jager-Krikken; F Kuipers; F Stellaard; C M Bijleveld; A Gouw; H Van Goor; R J Thompson; M Müller
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

3.  Mechanistic insights into isoform-dependent and species-specific regulation of bile salt export pump by farnesoid X receptor.

Authors:  Xiulong Song; Yuan Chen; Leila Valanejad; Rajani Kaimal; Bingfang Yan; Matthew Stoner; Ruitang Deng
Journal:  J Lipid Res       Date:  2013-09-03       Impact factor: 5.922

4.  Identification of a nuclear receptor for bile acids.

Authors:  M Makishima; A Y Okamoto; J J Repa; H Tu; R M Learned; A Luk; M V Hull; K D Lustig; D J Mangelsdorf; B Shan
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

5.  Discovery of sulfated sterols from marine invertebrates as a new class of marine natural antagonists of farnesoid-X-receptor.

Authors:  Valentina Sepe; Giuseppe Bifulco; Barbara Renga; Claudio D'Amore; Stefano Fiorucci; Angela Zampella
Journal:  J Med Chem       Date:  2011-02-10       Impact factor: 7.446

6.  Changes in serum bile acid concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching.

Authors:  J Heikkinen; O Mäentausta; P Ylöstalo; O Jänne
Journal:  Br J Obstet Gynaecol       Date:  1981-03

7.  Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.

Authors:  Yuan Chen; Xiulong Song; Leila Valanejad; Alexander Vasilenko; Vijay More; Xi Qiu; Weikang Chen; Yurong Lai; Angela Slitt; Matthew Stoner; Bingfang Yan; Ruitang Deng
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

8.  Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression.

Authors:  Aleksandra Cvoro; Christina Tzagarakis-Foster; Deirdre Tatomer; Sreenivasan Paruthiyil; Mark S Fox; Dale C Leitman
Journal:  Mol Cell       Date:  2006-02-17       Impact factor: 17.970

Review 9.  Pleiotropic functions of bile acids mediated by the farnesoid X receptor.

Authors:  B Stanimirov; K Stankov; M Mikov
Journal:  Acta Gastroenterol Belg       Date:  2012-12       Impact factor: 1.316

10.  A conserved lysine in the estrogen receptor DNA binding domain regulates ligand activation profiles at AP-1 sites, possibly by controlling interactions with a modulating repressor.

Authors:  Rosalie M Uht; Paul Webb; Phuong Nguyen; Richard H Price; Cathleen Valentine; Helene Favre; Peter J Kushner
Journal:  Nucl Recept       Date:  2004-05-07
View more
  11 in total

Review 1.  Immunology of hepatic diseases during pregnancy.

Authors:  Lars Bremer; Christoph Schramm; Gisa Tiegs
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

Review 2.  Immunological basis in the pathogenesis of intrahepatic cholestasis of pregnancy.

Authors:  Spencer P Larson; Oormila Kovilam; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2015-10-15       Impact factor: 4.473

Review 3.  Effect of Liver Disease on Hepatic Transporter Expression and Function.

Authors:  Nilay Thakkar; Jason R Slizgi; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2017-04-30       Impact factor: 3.534

4.  Nuclear Receptors in Pregnancy and Outcomes: Clinical Perspective.

Authors:  Luiza Borges Manna; Catherine Williamson
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  Maternal and Fetal Bile Acid Homeostasis Regulated by Sulfated Progesterone Metabolites through FXR Signaling Pathway in a Pregnant Sow Model.

Authors:  Peng Wang; Peiqiang Yuan; Sen Lin; Heju Zhong; Xiaoling Zhang; Yong Zhuo; Jian Li; Lianqiang Che; Bin Feng; Yan Lin; Shengyu Xu; Douglas G Burrin; Zhengfeng Fang
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

6.  Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression.

Authors:  Brandy Garzel; Tao Hu; Linhao Li; Yuanfu Lu; Scott Heyward; James Polli; Lei Zhang; Shiew-Mei Huang; Jean-Pierre Raufman; Hongbing Wang
Journal:  Pharm Res       Date:  2020-01-06       Impact factor: 4.200

7.  Differential Feedback Regulation of Δ4-3-Oxosteroid 5β-Reductase Expression by Bile Acids.

Authors:  Leila Valanejad; Christina Nadolny; Stephanie Shiffka; Yuan Chen; Sangmin You; Ruitang Deng
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

8.  Development of an adverse outcome pathway for intrahepatic cholestasis of pregnancy.

Authors:  Jennifer Waspe; Anna Beronius
Journal:  Curr Res Toxicol       Date:  2022-02-17

9.  Mechanistic insights into geniposide regulation of bile salt export pump (BSEP) expression.

Authors:  Guixin Wu; Min Wen; Lin Sun; Huitao Li; Yubei Liu; Rui Li; Feihua Wu; Rong Yang; Yining Lin
Journal:  RSC Adv       Date:  2018-11-05       Impact factor: 4.036

Review 10.  Molecular Pathogenesis of Intrahepatic Cholestasis of Pregnancy.

Authors:  Jianping Xiao; Zeying Li; Yutong Song; Yujie Sun; Hanfei Shi; Daozhen Chen; Yan Zhang
Journal:  Can J Gastroenterol Hepatol       Date:  2021-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.